INNOVATION FLOW

EXECUTIVE SUMMARY

CHALLENEGS FOR INDIAN TECHNOLOGY INNOVATORS THE BASIS OF A STRUCTURED APPROACH TO INNOVATION THE FOUR FACES OF AN INNOVATOR: BSKV MODEL THE FOUR RELIABLE METRICS TO MEASURE INNOVATION PROGRESS INNOVATION FLOW SCAMMPER TOOL THE OPEN INNOVATION MODEL CURRENT GLOBAL INITIATIVES FOR OPEN INNOVATION OPEN INNOVATION IN INDIA

CHALLENEGS FOR INDIAN TECHNOLOGY INNOVATORS

CHALLENGES

WHAT HOW

THE POOR CONEVRSION OF GREAT IDEAS INTO VALUABLE INNOVATION FAILURE OF TRANSFORMING IDEA TO INNOVATION CAUSES DISAPPOINTMENT OF ALL STAKEHOLDERS NEW PRODUCT DEVELOPMENT FALLS INTO COMA GOVERNMENT LABORATIES TO SMALL TECHNOLOGY START-UPS. WHEN MARKET IS AHEAD OF THE TECHNLOGY AND VICEVERSA MOST EMERGING ECONOMIES MOST DO NOT REALISE IMPORTANCE OF MONETIZING VALUABLE IP NO EFFECTIVE USE OF TECHNOLOGY TO BRING ABOUT DIFFERENTIATION

WHO FACES? WHEN? WHERE? WHY?

THE BASIS OF A STRUCTURED APPROACH TO INNOVATION

Insightful Idea
Observation Questioning Incubating Associating Experimenting

Strong Value Proposition

Improve useful functions Reduce harmful functions Reduce cost

Path to Market
Entrepreneurial thinking Strategic thinking Design Thinking Forecasting

THE FOUR FACES OF AN INNOVATOR: BSKV MODEL

SUCCESSFUL INNOVATIONS ACROSS DIFFERENT DOMAIN/ INDUSTRIES HAVE FOUR COMPONENTS IN COMMON :

GETTING AN INSIGHTFUL IDEA

FIGURING OUT HOW TO CREATE VALUE OUT OF IDEA

EXECUTING THE IDEA WELL FINALLY MAKING IT A SUCCESS IN THE MARKET

THE FOUR RELIABLE METRICS TO MEASURE INNOVATION PROGRESS

QUALITY OF IDEA

STRENGTH OF THE VALUE PROPOSITION

HOW WELL THE IDEA HAS BEEN EXECUTED?

HOW SUCCESSFUL IS IT IN THE MARKET?

INNOVATION FLOW

Observation Questioning

LEAP & ORIENT

Divergent thinking

Technology evolution trends Market trends

FOCUS

WHATS NEXT

SCAMMPER

INCREMENTAL TO DISRUPTIVE INNOVATION

How to improve useful functions ? How to reduce harmful functions ? How to reduce cost ?

Substitute Combine Adapt Maximize

Minimize
Put to other use Eliminate Reverse

THE OPEN INNOVATION MODEL

Open Source Drug Discovery (OSDD) is an open source code model of discovering a New Chemical Entity (NCE) or a New Molecular Entity (NME).

All data generated related to the discovery research will be available in the open for collaborative input

Driven by three key parameters OPEN DEVELOPMENT , OPEN ACCESS & OPEN SOURCE

Was successfully used in the Human Genome Project , to understand the mechanics of Proteins , by the IT Industry , Web Technology , etc.

THE OPEN INNOVATION MODEL

OBJECTIVES
To encourage drug discovery initiatives especially for the dreaded and the neglected diseases of the developing countries. To make the drugs affordable to the marginalized people of the world.

BENEFITS
Bringing together the best available minds to tackle extremely challenging diseases. Speed of innovation Risk sharing Affordability

ISSUES
Who will fund the project and how much ? Who will lead the project ? Who will coordinate the project and find talents ? Who will take it through clinical development and regulatory approval process ?

CURRENT GLOBAL INITIATIVES FOR OPEN INNOVATION

June 2008 GLAXOSMITHKLINE released the GENOMIC PROFILING DATA for over 300 sets of cancer cell lines for THE NATIONAL CANCER INSTITUTES BIOINFORMATIC GRID

The Alzheimers Disease Neuroimaging Initiative (ADNI)

GLAXOSMITHKLINE in collaboration with EUROPEAN BIOINFORMATICS INSTITUTE and NATIONAL LIBRARY OF MEDICINE, USA has announced Open Invitation Strategy to discover innovative drugs for malaria

OPEN INNOVATION IN INDIA

CSIRs(Council for Scientific and Industrial Research ) OPEN INNOVATION PROJECT Research on tropical diseases like Tuberculosis, Malaria, Leishmaniasis.

More than 2000 people have already registered for the project.

FUTURE PROJECT- Connect to decode- purpose is to completely reannonate Mtb genome.

CONCLUSION

WHERE WE ARE

Limited no. of scientists associated with the innovator company ,work on a project for commercial security reasons. This consumes a lot of time and funds.
WHAT WE NEED

Scientists and volunteers across the globe will be able to contribute to the project . This will lead to reduction in R&D costs and will also save a lot of time and thereby leading to cheaper drugs.

THANK YOU

Q&A